8. At the end⌠you will learnAt the end⌠you will learn
⢠Kidney disease can beKidney disease can be aa silent killersilent killer
⢠Childhood NS is mostly curableChildhood NS is mostly curable
⢠APSGN does nor recur; mostly recoversAPSGN does nor recur; mostly recovers
⢠Hematuria in small children is usually harmlessHematuria in small children is usually harmless
⢠With ageing most of us develop renal diseaseWith ageing most of us develop renal disease
⢠ARF in most cases can be preventedARF in most cases can be prevented
88
13. Importance of kidneyImportance of kidney
⢠MainMain waste excreterwaste excreter
⢠MaintainsMaintains fluid- and ABBfluid- and ABB
⢠MakesMakes erythropoietinerythropoietin
⢠Excretes someExcretes some drugsdrugs
⢠BiotransformsBiotransforms VDVD
1313
14. Peculiarities of Kidney DiseasesPeculiarities of Kidney Diseases
⢠May be asymptomaticMay be asymptomatic
⢠Symptoms can beSymptoms can be nonspecificnonspecific
⢠FewFew physical signsphysical signs
⢠May present withMay present with jaundicejaundice in infantsin infants
⢠Important c/ofImportant c/of FTTFTT
⢠Long UT means moreLong UT means more obstructionobstruction
1414
19. Micros. H:Micros. H: in a well child: ~in a well child: ~ no Ix.no Ix. ifif
not x3/over several mo.; evaluate ifnot x3/over several mo.; evaluate if
HTN, CKD, casturia/ proteinuriaHTN, CKD, casturia/ proteinuria
presentpresent
Gross H:Gross H: urine is red/tea/colaurine is red/tea/cola
colored; also mostly benigncolored; also mostly benign
Up to 5 rbc per HPF in urineUp to 5 rbc per HPF in urine
is normal in childrenis normal in children
1919
20. GH is more inGH is more in
boys. Assess byboys. Assess by
CF. VCUG isCF. VCUG is
useful inuseful in
doubtful USG,doubtful USG,
UTI, or voidingUTI, or voiding
problem.problem.
Cystoscopy ifCystoscopy if
persistent orpersistent or
with ambiguouswith ambiguous
imagingimaging
VCUG : voidingVCUG : voiding
cystourethrographycystourethrography 2020
23. A Case History: hematuriaA Case History: hematuria
A 12y-boy has hematuria. He has occasional darkA 12y-boy has hematuria. He has occasional dark
urine after heavy exercise but no gross hematuriaurine after heavy exercise but no gross hematuria
He does not use medicine. No h/of deafness; noHe does not use medicine. No h/of deafness; no
family h/of renal diseasefamily h/of renal disease
Physically normal:Physically normal: BP 130/80BP 130/80
Trace proteinuria and 10-15 rbc/hpf. No castsTrace proteinuria and 10-15 rbc/hpf. No casts
What is the most probable Dx?What is the most probable Dx?
2323
24. Isolated HematuriaIsolated Hematuria
⢠AsymptomaticAsymptomatic
⢠No features of NS/GNNo features of NS/GN
⢠Prevalence: 5-10% in the communityPrevalence: 5-10% in the community
Glomerular d. causes <10% of hematuria in pts. with noGlomerular d. causes <10% of hematuria in pts. with no
proteinuriaproteinuria
2424
25. Renal Function in NewbornRenal Function in Newborn
GFRGFR
â 5ml/ min in first week of life5ml/ min in first week of life
â 10ml/ min 1-2 mo10ml/ min 1-2 mo
â Preterm has lower GFRPreterm has lower GFR
2525
26. TerminologiesTerminologies
⢠Black water F:Black water F: (malaria hemolysis(malaria hemolysis:: hemoglobinuriahemoglobinuria))
⢠CKD/CRF:CKD/CRF: progressive RF over 3mo (Dm, HTN, GN)progressive RF over 3mo (Dm, HTN, GN)
⢠GN:GN: glomeruli and tubules inflamedglomeruli and tubules inflamed
⢠Mesangium:Mesangium: cells supporting glomeruli: phagocytic; maycells supporting glomeruli: phagocytic; may
contain molecules that may aid in Dxcontain molecules that may aid in Dx
2626
30. Causes of ARFCauses of ARF
⢠SevereSevere dehydrationdehydration
⢠Shock, ac.Shock, ac. hgehge
⢠BlockageBlockage of renal BV, oof renal BV, obstructionbstruction in UTin UT
⢠RenalRenal injuryinjury
⢠Ac.Ac. GN, aGN, acc. PN. PN
3030
31. ⢠HUS:HUS: destroysdestroys lininglining of BVof BV andand RBCRBC; often c/by; often c/by E.E.
colicoli; may get ARF or coagulopathy; may get ARF or coagulopathy
⢠Alport Syn.:Alport Syn.: inherited: x-linked. Hematuria,inherited: x-linked. Hematuria,
proteinuria; more serious in boys; leads to ESRD,proteinuria; more serious in boys; leads to ESRD,
hearing and visual losshearing and visual loss
⢠PKD:PKD:  inherited: grape-like cysts in kidneys; destroyinherited: grape-like cysts in kidneys; destroy
kidneys: CKD and ESRDkidneys: CKD and ESRD
HUS: hemolytic uremic syn. PKD: polycystic kidney DHUS: hemolytic uremic syn. PKD: polycystic kidney D
3131
32. ⢠Interstitial Nephritis:Interstitial Nephritis: Inflam. of supporting tissueInflam. of supporting tissue
of kidney; can lead to ARF/ESRDof kidney; can lead to ARF/ESRD
⢠Renal osteodystrophy:Renal osteodystrophy: RF causing weak bones;RF causing weak bones;
more in dialysis pts.: high PO4/low VDmore in dialysis pts.: high PO4/low VD
⢠RTA:RTA:  kidneys fail to remove acids normally: weakkidneys fail to remove acids normally: weak
bones, kidney stones and FTTbones, kidney stones and FTT
RTA: renal tubular acidosisRTA: renal tubular acidosis
3232
36. Goodpasture Syn.Goodpasture Syn. ((anti-GBM d)anti-GBM d)
⢠Autoim. pulmo-renal syn.: anti-collagen ABs inAutoim. pulmo-renal syn.: anti-collagen ABs in
lungs:lungs: vasculitis:vasculitis: hge., kidneys:hge., kidneys: GN (anti-GBM ABs)GN (anti-GBM ABs)
⢠It isIt is fatalfatal unless quickly Rxunless quickly Rx..
IgA NephropathyIgA Nephropathy ((Berger DBerger D):): RF is rareRF is rare
⢠Commonest GN in WestCommonest GN in West. IgA deposits after URTI:. IgA deposits after URTI:
silent hematuria; may go for yrssilent hematuria; may go for yrs
⢠Men more. All agesMen more. All ages
⢠No Rx for early/mild IgAN with normal BP and <1gNo Rx for early/mild IgAN with normal BP and <1g
24TUP: if more, Rx. with ACEI or ARBs24TUP: if more, Rx. with ACEI or ARBs
GBM: glomerular basement membrane. RF: renal failureGBM: glomerular basement membrane. RF: renal failure 3636
37. Paroxysmal Noc. Hb.uria (PNH)Paroxysmal Noc. Hb.uria (PNH)
Rare. Acquired. Some proteins cannot fix to RBCs toRare. Acquired. Some proteins cannot fix to RBCs to
protect from complement: hemolysis: Hb.emia andprotect from complement: hemolysis: Hb.emia and
Hb.uria; at night/early morningHb.uria; at night/early morning
⢠Any age. May causeAny age. May cause aplastic a., AML, MDSaplastic a., AML, MDS
⢠SS:SS: RAP, backache, HA, SoB, clotting; dark urine;RAP, backache, HA, SoB, clotting; dark urine;
easy bruisingeasy bruising
3737
38. Investigations for PNHInvestigations for PNH
⢠Pancytopenia,Pancytopenia, Hb.emia and hb.uriaHb.emia and hb.uria
⢠Coombs' test; haptoglobin levelCoombs' test; haptoglobin level
⢠Flow cytometry to measure certain proteinsFlow cytometry to measure certain proteins
⢠Ham's (acid hemolysin) testHam's (acid hemolysin) test
⢠Sucrose hemolysis testSucrose hemolysis test
⢠Urine hemosiderinUrine hemosiderin
3838
39. Rx for PNHRx for PNH
⢠Steroids/immunosuppressantsSteroids/immunosuppressants
⢠BT. Iron and B9. Blood thinnersBT. Iron and B9. Blood thinners
⢠EculizumabEculizumab can block hemolysiscan block hemolysis
⢠BMT can cureBMT can cure
⢠Vaccinations against certain types of bacteriaVaccinations against certain types of bacteria
Outlook:Outlook: most people survive >10 y after Dx. Deathmost people survive >10 y after Dx. Death
occur from thrombosis or bleedingoccur from thrombosis or bleeding
3939
40. GlomerulonephritisGlomerulonephritis
⢠Inflam. and proliferation of Glo. tissue with damageInflam. and proliferation of Glo. tissue with damage
to BM, mesangium or capillary endo.to BM, mesangium or capillary endo.
⢠Acute:Acute: hematuria, proteinuria and RBC casts. Oftenhematuria, proteinuria and RBC casts. Often
with HTN, edema and impaired RFwith HTN, edema and impaired RF
⢠ChronicChronic: scarring of nephrons with progressive RF: scarring of nephrons with progressive RF
4040
41. Ac NephriticAc Nephritic
(Glomerulonephritic)(Glomerulonephritic) Syn.Syn.
⢠Ac. inflam. of the glomeruli and nephronsAc. inflam. of the glomeruli and nephrons
Nephrotic Syn.Nephrotic Syn.
⢠Affection of nephrons with leakage ofAffection of nephrons with leakage of
protein (usually noprotein (usually no inflam.)inflam.)
4141
43. APSGNAPSGN
⢠15% of all GAS infx.; mostly RTI (skin 10%)15% of all GAS infx.; mostly RTI (skin 10%)
⢠2% clinically overt.2% clinically overt. Lag period: 2-3w.Lag period: 2-3w.
⢠No recurrenceNo recurrence
⢠Any AgeAny Age (2-15y; 2% <2y; 10% >40y). Boys >(2-15y; 2% <2y; 10% >40y). Boys >
⢠Excellent prognosisExcellent prognosis:: <2% MR. 2% CGN<2% MR. 2% CGN
⢠Cerebral vasculitis may occurCerebral vasculitis may occur
GAS: group A streptococci
4343
44. PathophysiologyPathophysiology
ďś Exact mechanism is unclear. Autoim. D: both CMIExact mechanism is unclear. Autoim. D: both CMI
and humoral.and humoral. Immune complexImmune complex in glomeruli: activatesin glomeruli: activates
complement: inflam.complement: inflam.
ďś Strep.Strep. does not attack the kidneydoes not attack the kidney
ďśKidneys may enlarge ~50%Kidneys may enlarge ~50%
ďś Histology:Histology: swelling of glomeruli, polymorphs,swelling of glomeruli, polymorphs,
infiltration.infiltration. IF:IF: deposition of Ig and complementdeposition of Ig and complement
4444
49. Renal BiopsyRenal Biopsy
⢠Declining RFDeclining RF
⢠Atypical presentationAtypical presentation
⢠F/history of renal DF/history of renal D
⢠Persistent HTN or gross hematuria andPersistent HTN or gross hematuria and
-hypocomplementemia-hypocomplementemia
⢠Hallmark in PSGNHallmark in PSGN is subepithelial âhumpsâis subepithelial âhumpsâ
representing immune complex depositionrepresenting immune complex deposition
4949
50. DiagnosisDiagnosis
⢠CF, swab CS, positive ASO and/or anti DNase BCF, swab CS, positive ASO and/or anti DNase B
⢠C3 is typically low (normalizes 6- 12w). But normalC3 is typically low (normalizes 6- 12w). But normal
C3 does not exclude itC3 does not exclude it
DDDD
⢠IgANIgAN
⢠HSP, SLEHSP, SLE
⢠HUS, other infx.HUS, other infx.
5050
51. Henoch-Schonlein purpuraHenoch-Schonlein purpura
⢠70% affect kidneys: MC hematuria +/- proteinuria70% affect kidneys: MC hematuria +/- proteinuria
⢠HistologicallyHistologically IgANIgAN
⢠May relapseMay relapse
⢠Severe: steroids, azathioprineSevere: steroids, azathioprine
⢠Follow until urinalysis normalFollow until urinalysis normal
⢠5-20% of children end in ESRF5-20% of children end in ESRF
5151
52. Rx Of PSGNRx Of PSGN
⢠Supportive. ~Supportive. ~ Bed restBed rest
⢠Fluid and salt restriction.Fluid and salt restriction. FEBFEB
⢠Rx of hyperkalemia.Rx of hyperkalemia. No fruits!No fruits!
⢠Penicillin x 10d:Penicillin x 10d: why?why?
⢠BP control. ACE inhibitors can cause hyperkalemiaBP control. ACE inhibitors can cause hyperkalemia
⢠Rx of complicationsRx of complications
⢠Admission if renal failureAdmission if renal failure
5252
53. Complications of AGNComplications of AGN
⢠ARF (uremia/azotemia)ARF (uremia/azotemia)
⢠CGN: 2%CGN: 2%
⢠Volume over-load: HTN: LVFVolume over-load: HTN: LVF
â HTN: encephalopathy, convulsionHTN: encephalopathy, convulsion
⢠Hyperkalemia, acidosisHyperkalemia, acidosis
⢠Microhematuria may persist for yearsMicrohematuria may persist for years
⢠NSNS
5353
54. APSGN: Prognosis:APSGN: Prognosis: excellentexcellent
⢠Mortality 2%.Mortality 2%. CKD: 2% in children.CKD: 2% in children. 30% in adults30% in adults
⢠ESRD 1-2%ESRD 1-2%
⢠One attack confers lifelong immunityOne attack confers lifelong immunity
⢠Almost all APSGN recover completelyAlmost all APSGN recover completely
5454
55. S/o Glomerular DiseasesS/o Glomerular Diseases
⢠May be silent for many yearsMay be silent for many years
⢠Hematuria, proteinuria, azotemiaHematuria, proteinuria, azotemia
⢠HTN, edema, hyperlipidemiaHTN, edema, hyperlipidemia
GN and G. sclerosis include many forms of glomerularGN and G. sclerosis include many forms of glomerular
damage. Some RF can be slowed down, but scarreddamage. Some RF can be slowed down, but scarred
glomeruli cannot be repairedglomeruli cannot be repaired
5555
56. GlomerularGlomerular vsvs Non-G Hematuria?Non-G Hematuria?
⢠Chemical trauma to RBC as they pass throughChemical trauma to RBC as they pass through
nephrons causes peculiar changes: they losenephrons causes peculiar changes: they lose
biconcavity and have blebs:biconcavity and have blebs: âMickey Mouse CellsââMickey Mouse Cellsâ
⢠RBC casts and proteinuria supports a GDRBC casts and proteinuria supports a GD
5656
59. Case history:Case history: A 3y old child has heavy proteinuria withA 3y old child has heavy proteinuria with
anasarca. No familial KD. He is not on any drugs. Wt 17 kganasarca. No familial KD. He is not on any drugs. Wt 17 kg
(14Kg), BP 90/50; 4+edema(14Kg), BP 90/50; 4+edema
Urine: 0-4 RBC/hpf. Numerous hyaline casts. Some lipidUrine: 0-4 RBC/hpf. Numerous hyaline casts. Some lipid
inclusions appearing Maltese cross under polarized lightinclusions appearing Maltese cross under polarized light
What is the Dx?What is the Dx?
5959
60. Glomerular vs. Tubular ProteinuriaGlomerular vs. Tubular Proteinuria
TraitsTraits TubularTubular GlomerularGlomerular
Sp. Gr. Of urineSp. Gr. Of urine IsosthenuricIsosthenuric High (conc.)High (conc.)
ProteinProtein 1+1+ âĽâĽ 3+3+
HematuriaHematuria Usually nilUsually nil OftenOften
CastsCasts Tubular cells/Tubular cells/
nonenone
Variable (RBC,Variable (RBC,
granulargranular
UP ElectrophoresisUP Electrophoresis Broad band âBroad band â
multiple globulinmultiple globulin
Albumin peakAlbumin peak
6060
61. Nephrotic SyndromeNephrotic Syndrome
⢠Massive proteinuria >3.5g/d (>40mg/mMassive proteinuria >3.5g/d (>40mg/m22
/h)/h)
⢠Hypoalbuminemia: <30g/dlHypoalbuminemia: <30g/dl
⢠Anasarca: water pooling. Ac. wt. gainAnasarca: water pooling. Ac. wt. gain
⢠HyperlipidemiaHyperlipidemia
⢠LipiduriaLipiduria
Age: 1½ - 5y. Boys moreAge: 1½ - 5y. Boys more
6161
63. PeculiaritiesPeculiarities of Childhood NSof Childhood NS
⢠Mostly no inflammation/RFMostly no inflammation/RF
⢠Most respond to steroidMost respond to steroid
⢠Well for 3y: no more relapseWell for 3y: no more relapse
⢠No relapse after 15y ageNo relapse after 15y age
⢠Auto-remission 5%Auto-remission 5%
6363
66. ⢠Steroid sensitive (90%)
⢠Steroid resistant: no response in 4w (10%)
⢠Steroid dependent: relapse on 2 consecutive
occasions as steroid is being tapered or within 2w
of withdrawal
⢠Remission: nil protein morning urine x 3d
⢠Relapse: UP: >40/m2/h or Albustix âĽ++ x 3d
morning urine. Frequent R: âĽ2 Rs in 6mo of Dx. or
âĽ4 R/y. Infrequent R: after 3 mo of remission
6666
67. PathophysiologyPathophysiology
⢠Non-immuneNon-immune factors in MCD and FSGSfactors in MCD and FSGS
⢠Immune factors in MPGN, PSGN and SLEImmune factors in MPGN, PSGN and SLE
⢠Mutations in podocyte or slit diaphragm inMutations in podocyte or slit diaphragm in
inherited, infantile or steroid resistant NSinherited, infantile or steroid resistant NS
⢠Incidence: 2-7/100,00/yIncidence: 2-7/100,00/y
⢠x15 common in childrenx15 common in children
⢠Age of onset varies with type of diseaseAge of onset varies with type of disease
6767
68. Filtration barrier. A. The endothelium with fenestra
B. GBM: 1. lamina interna 2. L. densa 3. L. externa
C. Podocytes: 1. enzymatic and structural protein 2. filtration slit 3.
diaphragma 6868
69. MCDMCD
⢠Major c/of NS in children
⢠Light ME: Normal
⢠EM: fusion of foot processes of visceral epith cells
⢠IF: no immune complex deposit
⢠Cause/mechanism unknown
⢠Drammatic response to steroid
⢠Excellent prognosis
6969
70. Focal Segmental GlomerulosclerosisFocal Segmental Glomerulosclerosis (FSGS)(FSGS) andand
Membranoproliferative GNMembranoproliferative GN (MPGN)(MPGN)
⢠In about 15% of childhood NS, a kidney biopsyIn about 15% of childhood NS, a kidney biopsy
shows scarring or deposits in glomerulishows scarring or deposits in glomeruli
⢠Steroid is less effective in these; need cytotoxicSteroid is less effective in these; need cytotoxic
⢠ACEI can decrease HTN and proteinuria and protectACEI can decrease HTN and proteinuria and protect
kidneyskidneys
7070
71. C/FC/F
⢠M: F =2:1M: F =2:1
⢠Gross edema, scantyGross edema, scanty
urine, SoBurine, SoB
⢠There may be anThere may be an
antecedal URTI (specially in relapse)antecedal URTI (specially in relapse)
Others:Others: depression, lethargy, anorexia, skin striae,depression, lethargy, anorexia, skin striae,
diarrhea, AP, orthostatic hypotensiondiarrhea, AP, orthostatic hypotension
Bedside urine: heavy proteinuriaBedside urine: heavy proteinuria
7171
74. InvestigationsInvestigations
⢠Urine RE, CSUrine RE, CS
⢠UTP/spot urine ACR: >200UTP/spot urine ACR: >200
⢠CBC, electrolytes, BUN, S. Cr., STP, AG ratio,CBC, electrolytes, BUN, S. Cr., STP, AG ratio,
cholesterol (specifically LDL)cholesterol (specifically LDL)
⢠ANA; Anti-dsDNA, C3, HBsAg, HCVANA; Anti-dsDNA, C3, HBsAg, HCV
⢠Renal USGRenal USG
⢠CXR, MT, worms, before steroid RxCXR, MT, worms, before steroid Rx
DD:DD: CHF, cirrhosis, protein losing statesCHF, cirrhosis, protein losing states 7474
75. Renal BiopsyRenal Biopsy
RarelyRarely done in Paediatric cases. Consider:done in Paediatric cases. Consider:
⢠Cong. NSCong. NS
⢠>8 y at onset>8 y at onset
⢠Steroid resistanceSteroid resistance
⢠Frequent relapsesFrequent relapses
⢠Significant nephritic featuresSignificant nephritic features
7575
76. ComplicationsComplications
⢠Infection:Infection: loss of Ig, complement: UTI, SBPloss of Ig, complement: UTI, SBP
(commonest) and pneumonia(commonest) and pneumonia (pneumococcus)(pneumococcus)
⢠Thrombosis:Thrombosis: loss of anti thrombin iii, antiplasminloss of anti thrombin iii, antiplasmin
and proteins S&C in urine, more coagulants byand proteins S&C in urine, more coagulants by
liver, raised hct., relative immobility, steroidliver, raised hct., relative immobility, steroid
⢠Hypovolemia:Hypovolemia: postural hypotensionpostural hypotension
⢠Drug toxicity:Drug toxicity: steroid, nephrotoxcity fromsteroid, nephrotoxcity from
cyclosporin A or tacrolimuscyclosporin A or tacrolimus
7676
77. Management: generalManagement: general
⢠CheckCheck BP, wt, abdo. girth, IO chart, proteinuriaBP, wt, abdo. girth, IO chart, proteinuria
⢠Bed rest in gross edemaBed rest in gross edema
⢠Diet: lean protein, low fat; low-saltDiet: lean protein, low fat; low-salt
⢠Salt and fluid restriction. UsuallySalt and fluid restriction. Usually no diureticno diuretic
⢠Hypovolemia and hypoalbuminemia: FFP 20ml/kgHypovolemia and hypoalbuminemia: FFP 20ml/kg
or salt poor albumin 20%or salt poor albumin 20%
⢠Anticoagulants can help decrease clottingAnticoagulants can help decrease clotting
⢠Statins can help lower cholesterolStatins can help lower cholesterol
7777
78. SpecificSpecific
⢠Objective:Objective: Rx underlying causeRx underlying cause
⢠MCD: up to 8 year age: no renal biopsyMCD: up to 8 year age: no renal biopsy
⢠Prednisolone 60mg/m2/dPrednisolone 60mg/m2/d x 4 wx 4 w, then, then 40mg/m2/d40mg/m2/d
EAD for 4wEAD for 4w then STOPthen STOP
7878
79. RelapseRelapse
⢠First 2: âtreat same wayâFirst 2: âtreat same wayâ
⢠Frequent R: keep steroid 0.5mg/kg EAD for 3-6 mo.Frequent R: keep steroid 0.5mg/kg EAD for 3-6 mo.
If relapse: Levamisole EAD for 4-12 moIf relapse: Levamisole EAD for 4-12 mo
⢠If still R:If still R: Cyclophosphamide x 8w plus Low DoseCyclophosphamide x 8w plus Low Dose
PredPred
⢠Still rStill relapse: Cyclosporin A for 1y plus LD Predelapse: Cyclosporin A for 1y plus LD Pred
⢠Other drugs: Tacrolimus, Mycophenolate mofetilOther drugs: Tacrolimus, Mycophenolate mofetil
7979
80. SRNSSRNS
⢠Refer to specialized unit
⢠Full remission not achieved
⢠Aim: lower proteinuria to not-in-nephrotic range
⢠Risk of HTN and renal failure
⢠In FSGS: 20-40% risk of relapse post transplant
8080
81. DDDD
SSNSSSNS
⢠Toddler, pre-school
⢠No HTN
⢠Mild, intermittent
haematuria
⢠Normal renal function
⢠Excellent prognosis,
even if frequently
relapsing
⢠No biopsy
SRNSSRNS
⢠<1 year, > 8 y
⢠HTN common
⢠Persistent haematuria
⢠Often abnormal RF
⢠Long term HTN and RF
⢠Biopsy needed: usual
histology FSGS
8181
82. Congenital NSCongenital NS
⢠First 3 mo of life. Large placenta ~ 40% of BW
⢠Drug resistant. High morbidity: PEM & sepsis
⢠Types:Types: Finnish type: most severe, AR. Diffuse
mesangial sclerosis: less severe, AR. Denys-Drash
syn.: pseudohermaphroditism and Wilmâs T. FSGS.
Secondary CNS: cong. syphilis
⢠Rx.: Intensive care: 20% albumin, nutrition, early
unilateral nephrectomy, RRT
8282
83. Rx of Hypertension in NS
⢠ACEI reduce BP and proteinuria
⢠Nifedipine 0.25mg/kg/dose s.l.; max 8 doses/d
(not >2mg/kg/d or
⢠Hydralazine 0.5-2mg/kg/d)
⢠Others: Atenolol, Methyldopa
⢠Diuretic is controversial. Use with caution. May be
dangerous in hypovolemia
8383
84. Immunization in NS
Prednisolone 2mg/kg/d or 20mg/kg/d x 14d:
immunocompromized
⢠No live vax.
⢠Killed vax./toxoids are safe
⢠Live vax. after 4w of stopping steroid
⢠VZIG in case of exposure
⢠Ig in case of measles expo. or cl. measles
8484
85. Trait NS APSGN
H/o Nil Preceding Strep. Inf.
Age 2-6y 5-15y
Edema Massive Mild-moderate
Urine color Clear Coca-cola colored
Sediment Nil Red colored
Protein 4+ 1-2+
Microscopy Clear Plenty RBCs, PC
Casts Hyaline RBC casts
Serum albumin Below 25g/dl Normal
8585
87. MCQMCQ
⢠In APSGN ABT is essential for the pt.In APSGN ABT is essential for the pt.
⢠APSGN is an autoimmune DAPSGN is an autoimmune D
⢠Strep. skin infx. can cause RhFStrep. skin infx. can cause RhF
⢠Fruits are beneficial in APSGNFruits are beneficial in APSGN
⢠In APSGN LVF can occur from myocarditisIn APSGN LVF can occur from myocarditis
⢠Hyperkalemia is a recognized complication ofHyperkalemia is a recognized complication of
APSGNAPSGN
8787
Rural Bangladesh scenario: a small child fondled using coconut leaf as baby carrier
An old dictum: â1 should investigate hematuria rather than treat it&quot;. Most frequent c/of: UTIâs, stones and tumors
Wilms T: is a kidney Ca in children. Causes: the commonest childhood kidney cancer. Cause is unknown. aniridia is sometimes associated. Other birth defects linked to this: certain UT problems and hemihypertrophy. more common among some siblings and twins (possible genetic cause). It occurs most often 3y age; rare after 8
Symptoms: any of: AP, Abnormal urine color, Constipation, F, malaise, HTN, Increased growth on only one side of the body, ANV, abdominal hernia or mass, FH of Ca, aniridia
Exams and Tests: PE: Â abdominal mass, HTN, Abdominal USG, AXR, BUN, CXR, CBC, Creatinine, CCr, CT abdo, IVU, Urinalysis, Other tests may be required to determine if the tumor has spread.
Rx: do not prod or push on the child&apos;s belly area. Use care during bathing and handling to avoid injury to it.
Stage: to determine how far it has spread and to plan for the best Rx. Surgery to remove the T is scheduled as soon as possible. Surrounding tissues and organs may also need to be removed if the tumor has spread.
Radiation therapy and chemotherapy will often be started after surgery, depending on the stage of the tumor.
Prognosis: Children whose tumor has not spread have a 90% cure rate.
Possible Complications: may be quite large, but usually remains self-enclosed. Spread of the tumor to the lungs, liver, bone, or brain is the most worrisome complication.
HTN and kidney damage may occur as the result of the tumor or its treatment.
Removal of it from both kidneys may affect kidney function.
Prevention: with a high risk of WT, screening ultrasound of the kidneys may be recommended.
Alternative Names: Nephroblastoma; Kidney tumor
HSP: best characterized as a immune-related, small-vessel vasculitis. There are IgA- and C3-containing immune complex deposits in BV and elsewhere, cause is unknown. CF: Purpura, Abdominal and Renal features, Arthritis. Commonest in 3-8y (commonest vasculitis of childhood), incidence: 20/100,000 children/y; occurs in adults too. Many have a strong h/o atopy, and usually following URTI. It may be the deposition of IgA and C3 is related to an overzealous immune response to a preceding inf. The classic triad: purpura, arthritis and AP â but not all pts. have all 3. All HSP have the skin lesions, 80% have arthritis or joint p, and 60% AP. Purpuras consist of subepidermal hge and a necrotizing vasculitis involving the small BV of the dermis; usually extensor surfaces of arms and legs, and sometimes the buttocks. Abdominal: AP, V, and intestinal bleeding. Vasculitis may be present in the GI tract too. Renal: in 1/3 cases: commonest is hematuria (gross or microscopic) â but a small number of pts. develop GN/NS. In adults: renal features are more severe and may evolve into a rapidly progressive, crescentic GN. By immunofluorescence, there is prominent deposition of IgA (sometimes IgG and C3) in the mesangial region; pattern looks so much like IgA nephropathy (best to think of HSP and IgAN as faces of the same d).
Rx is usually symptomatic. Steroids may reduce the chance of severe renal d, but they are used sparingly. The prognosis in kids is excellent (90% recover completely). In some cases, the d recurs, usually manifesting with bouts of hematuria
Glomerular mesangium is a structure associated with the capillaries. It is continuous with the smooth muscles of the arterioles. It is outside the capillary lumen, but surrounded by capillaries. It is in the middle (meso)Â
between the capillaries (angis). Both are contained by same BM.
This term is often used interchangeably with mesangial cell, but in this context refers specifically to the
intraglomerular mesangial cells.
These cells are phagocytic and secrete BM (mesangial matrix). They are typically separated from the lumen of
the capillaries by endothelial cells
ESRD: end stage renal disease
ATN: ac. Tubular necrosis
Alport Syndrome? (British Cecil A. Alport, 1927 ). He observed hematuria as the commonest and males affected more severely. AS can also affect cochlea and eye
Prevalence: 1/5,000. C/by mutations affecting type IV collagen, a major part of basement m. 80% X-linked. 20% is AR/AD
Kidneys: always affected. Hematuria is usually microscopic; sometimes for several days, associated with a cold or flu. This gross hematuria eventually stops when the child recovers and can be very frightening but is not harmful. As boys get older, they begin to show additional signs: proteinuria and HTN. These usually occur by the time the boys are teenagers. AS causes damage to the kidneys by formation of scar (glomeruli and tubules). Proteinuria damages the filtering system or glomeruli because of the abnormal collagen makeup (fibrosis: CKD). X-linked Alport develops CRF by the teenage years or early adulthood, but the onset of kidney failure can be delayed 40-50y of age. Carriers have no kidney failure. However, as women age, the risk of kidney failure increases.
Boys and girls with the AR form will develop CRF by their teens or young adult years. AD is usually well into middle age before CRF
Inner Ear: Hearing loss is never present at birth but becomes apparent by late childhood or early adolescence, generally before CRF. Some families have no deafness. Hearing aids are usually v effective. 80% of boys with X-linked AS develop hearing loss at some point in their lives, often by the time they are teenagers. In girls with X-linked AS hearing loss is less frequent and occurs later in life. AR typically have childhood hearing loss. Patients with AD develop hearing loss at a later age
Eyes: Anterior lenticonus is an abnormality in the shape of the lens of the eye (15-20% of X-linked and AR). People with anterior lenticonus may have a slow progressive deterioration of vision requiring patients to change the prescription of their glasses frequently. This condition may also lead to cataract formation. Some people have abnormal pigment of the retina called dot-and-fleck retinopathy, but this does not result in any abnormalities of vision. Recurrent corneal erosion can occur; and may need to take measures to protect their corneas from minor trauma such as wearing goggles when riding a bicycle
Anti-neutrophil cytoplasmic Ab (ANCAs): ABs mainly IgG, against AGs in neutrophil and monocyte cytoplasm. Seen in some autoimmune D. Particularly associated with systemic vasculitis (ANCA vasculitides)
MDS: myelodysplastic syn. CW: cell wall. SoB: short of breathing
PNH (Marchiafava-Micheli syn.), is a rare, generally acquired, life-threatening d of blood characterized by complement-induced intravascular hemolysis, hemoglobinuria and thrombosis. PNH is the only hemolytic a. which is mostly c/by an acquired intrinsic defect in the cell membrane (deficiency of glycophosphatidylinositol leading to absence of protective proteins on the membrane). It may develop on its own (&quot;primary PNH&quot;) or in the context of other BM d like aplastic a.  (&quot;secondary PNH&quot;). 26% have the telltale red urine in the morning that originally gave the condition its name. Allogeneic BMT is the only cure, but has significant rates of both MM. The MAb eculizumab (Soliris) is effective at reducing the need for BT, improving QoL, and reducing the risk of thrombosis
Gene is called PIG-A.Â
BMT: BM transplantation
IF: Immunofluorescence
Anti-DNase B: looks for ABs to a substance made by GAS. Raised levels: Rheumatic F, PSGN, Strep. Throat/skin infection
FEB: fluid and electrolyte balance
Isosthenuric: like of plasma
Podocytes (visceral epithelial cells): cells in the B. capsule that wrap capillaries with long processes, (foot ..)  The capsule filters blood but proteins. They have slits between them (slit diaphragm or filtration slit). Podocytes can regulate GFR by contraction: closure of filtration slits: low GFR. Disruption of slits or destruction of podocytes cause massive proteinuria